25% healthcare staff infected despite taking 2 jabs in Delhi: Study

New Delhi: A little more than 25 per cent of healthcare workers were infected with coronavirus despite getting fully jabbed, a recent study has revealed, giving an insight on the breakthrough infections due to the Delta variant.

The study, jointly conducted by the Institute of Genomics and Integrative Biology (IGIB) and Max hospitals in Delhi-NCR, found that vaccination breakthroughs were far more common during the Delta-outbreak in Delhi than previously reported.

However, the severity of the infection was low and vaccination is crucial to avoid severe illnesses, said Shantanu Sengupta, senior scientist with the IGIB and one of the lead researchers of the study.

He also cautioned that of the 25 per cent who were infected, a large number were asymptomatic, so masking is also very important to arrest the spread of infection.

Sengupta said nearly 95 healthcare workers who had taken the two doses were studied. They were assessed from 45-90 days after their inoculation. Of the 95, more than 25 per cent saw breakthrough infections.

“Immunisation is expected to confer protection against infection and severe disease for vaccines, while reducing risks to non-immunised population by inhibiting transmission. Here, based on serial serological studies, we show that during a severe SARS-CoV2 Delta-variant outbreak in Delhi, 25.3 per cent of previously uninfected, ChAdOx1-nCoV19 (Covishield) double vaccinated, healthcare-workers (HCW) were infected within a period of less than two months, based on serology,” the study said.

Most infections were unrecognised. PTI

  • Related Posts

    Nebuliser, inhaler demand for children jumps by up to 60 pc in Delhi winters: Survey

    New Delhi:  The demand for nebulisers, inhalers and respiratory medicines for children has surged sharply in Delhi during winter months, with chemists reporting spikes of up to 60 per cent…

    Pharma company, its employees convicted for ‘illegal diversion” of meth precursor abroad

    Rajkot: The Narcotics Control Bureau (NCB) on Monday said it has secured a “major conviction” in the case of illegal diversion of medical drugs involving a Haryana-based company via Gujarat’s Pipavav…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Nebuliser, inhaler demand for children jumps by up to 60 pc in Delhi winters: Survey

    Nebuliser, inhaler demand for children jumps by up to 60 pc in Delhi winters: Survey

    Pharma company, its employees convicted for ‘illegal diversion” of meth precursor abroad

    Pharma company, its employees convicted for ‘illegal diversion” of meth precursor abroad

    Ayurveda practitioner fined by ISM Council for violation of professional ethics

    Ayurveda practitioner fined by ISM Council for violation of professional ethics

    Administering rabies vaccine at the wrong site can be fatal: Shoulders or thighs only, warn experts

    Administering rabies vaccine at the wrong site can be fatal: Shoulders or thighs only, warn experts

    Delhi HC allows Zydus to sell biosimilar of blockbuster anti-cancer drug Nivolumab

    Delhi HC allows Zydus to sell biosimilar of blockbuster anti-cancer drug Nivolumab

    DoP may exempt 11 more drugs from public procurement rules

    DoP may exempt 11 more drugs from public procurement rules